Investigators evaluated the safety of coadministration of muscle relaxants and opioids among patients receiving long-term opioid therapy.
Researchers sought to examine patterns in CVD deaths and subtypes myocardial infarction, stroke, and heart failure prepandemic vs during the COVID-19 pandemic.
Researchers applied and compared QRISK3 with the adjusted global antiphospholipid syndrome score in patients with systemic lupus erythematosus in order to assess their risk for developing cardiovascular diseases.
Gregory M Marcus, MD, MAS, and Jeffrey J. Hsu, MD, PhD, discuss the effect of caffeine and energy supplements on risk for cardiovascular events.
Researchers evaluated the association between C-reactive protein levels and the 10-year risk for cardiovascular disease in patients with rheumatoid arthritis.
A team of investigators assessed patterns of statin therapy prescribed to patients with atherosclerotic cardiovascular disease with comorbid nondialysis chronic kidney disease.
Researchers evaluated the cardiovascular safety of hydroxychloroquine vs methotrexate among patients with rheumatoid arthritis.
Tamara Horwich, MD, Eugenia Gianos, MD, and Kenneth Fleisher, DDS, reflect on the link between cardiovascular disease and oral health.
Researchers studied the relationship between the total burden of arterial plaque and cardiovascular disease risk in patients with systemic lupus erythematosus.
These recommendations only apply to individuals who do not have a history of CVD and are not already taking daily aspirin.